Seeking Alpha
Long/short equity, contrarian, short-term horizon, dividend investing
Profile| Send Message|
( followers)  

This is Part V of earnings being reported on Tuesday. There are quite a few market moving stocks reporting earnings. It is not hard to tell we are right in the middle of earnings season. Due to the quantity of companies reporting I am focusing on the highest volume traded stocks. It is easy to see we are in the middle of earnings season when it takes this many parts to go over the biggest companies reporting in one day.

Illumina Inc. (NASDAQ:ILMN) is a $9.17 billion market cap developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics.
The company reported (basic) $0.19 per share in earnings for the quarter ending April 3, 2011. The Quick Ratio is 2.09 (generally the higher the better). The next reporting quarter estimated mean earnings are $0.36 per share. Analyst estimates range between $0.31 and $0.39 per share.

The current trailing twelve months (ttm) P/E ratio is 85.598 and the forward P/E ratio is 38.19. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 7.59. The price to sales ratio is 10.06. Looking at the chart and the numbers it would appear that a miss with earnings could cause the stock to fall hard, maybe into the lower $60s. Those considering investing in this company should take a look at protective put options and/or writing call options to maintain sanity if they should miss. The chart suggests that growth is being priced into the stock, with investors expecting a good report.

In the last month the stock has moved in price -0.21%, with a one year change of -0.29%. Comparing to the S&P 500 price change, Illumina Inc's performance is 4.7% vs. the S&P 500 from a month ago, and the one year difference is 6.56% vs. S&P 500 price change.

The annual growth rate of revenue is 35.48%. The last fiscal year had accounts receivable to sales percentage of 0.1834% compared to the same period a year earlier of 0.2367%.
Illumina Inc. has rising revenue year-over-year of $902.74 million for 2010 vs. $666.32 million for 2009. The bottom line has rising earnings year-over-year of $124.89 million for 2010 vs. $72.28 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $211.65 million for 2010 vs. $125.60 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.310.350.0413.45%
Dec-100.290.2900.00%
Sep-100.240.30.0623%
Jun-100.230.260.0314.39%
Mar-100.190.210.0210.06%

Dreamworks Animation Skg, Inc. (NASDAQ:DWA) is a $1.76 billion market cap company. DreamWorks Animation SKG, Inc. (DreamWorks Animation) is engaged in the development, production and exploitation of animated films and characters in the worldwide theatrical, home entertainment, television, merchandising, licensing and other markets. DreamWorks Animation creates family entertainment, including animated feature films, television specials and series, live entertainment properties, an online virtual world and related consumer products, meant for audiences around the world.
The company reported (basic) $0.1 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 0.96. The next reporting quarter estimated mean earnings are $0.4 per share. Analyst estimates range between $0.15 and $0.86 per share.



The current trailing twelve months (ttm) P/E ratio is 11.566 and the forward P/E ratio is 13.16. A rising P/E ratio is usually not what we want to see for an investment. The stock has a price to book ratio (ttm) of 2.04. The price to sales ratio is 3.27.




The annual growth rate of revenue is 8.22%. The last fiscal year had accounts receivable to sales percentage of 0.0515% compared to the same period a year earlier of 0.0706%.
Dreamworks Animation Skg, Inc. has rising revenue year-over-year of $784.79 million for 2010 vs. $725.18 million for 2009. The bottom line has rising earnings year-over-year of $170.64 million for 2010 vs. $151.04 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $166.84 million for 2010 vs. $193.30 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.100.100.00%
Dec-100.730.990.2635.51%
Sep-100.350.470.1232.84%
Jun-100.220.270.0520.48%
Mar-100.220.240.028.65%

Simon Property Group Inc. (NYSE:SPG) is a $35.78 billion market cap operates as a self-administered and self-managed real estate investment trust (REIT). Simon Property Group, L.P., the Operating Partnership, is the Company’s partnership subsidiary, which owns all of its real estate properties.
The company reported (basic) $0.61 per share in earnings for the quarter ending March 31, 2011. The next reporting quarter estimated mean earnings are $1.58 per share. Analyst estimates range between $1.51 and $1.67 per share.

The current trailing twelve months (ttm) P/E ratio is 45.466 and the forward P/E ratio is 17.16. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 7.39. The price to sales ratio is 9.02.

In the last month the stock has moved in price 8.37%, with a one year change of 41.14%. Comparing to the S&P 500 price change, Simon Property's performance is 2.2% vs. the S&P 500 from a month ago, and the one year difference is 14.77% vs. S&P 500 price change.

The annual growth rate of revenue is 4.83%. The last fiscal year had accounts receivable to sales percentage of 0.2723% compared to the same period a year earlier of 0.2741%. For the trailing twelve months investors received $2 in dividends for a yield of 2.63%.


Simon Property has rising revenue year-over-year of $3.96 billion for 2010 vs. $3.78 billion for 2009. The bottom line has rising earnings year-over-year of $610.42 million for 2010 vs. $283.10 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $1.74 billion for 2010 vs. $1.41 billion for 2009.

QEP Resources, Inc. (NYSE:QEP) is a $7.9 billion market cap independent natural gas and oil exploration and production company. QEP is a holding company with three lines of business: gas and oil exploration and production, midstream field services, and energy marketing, which are conducted through three principal subsidiaries.
The company reported (basic) $0.42 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 0.92. The next reporting quarter estimated mean earnings are $0.33 per share. Analyst estimates range between $0.21 and $0.39 per share.

The current trailing twelve months (ttm) P/E ratio is 30.814 and the forward P/E ratio is 20.59. The stock has a price to book ratio (ttm) of 2.14. The price to sales ratio is 2.87.

In the last month the stock has moved in price 10.27%, with a one year change of 48.83%. Comparing to the S&P500 price change, Qep Resources, Inc.'s performance is 3.99% vs. the S&P 500 from a month ago, and the one year difference is 21.02% vs. S&P 500 price change.

The annual growth rate of revenue is 13.89%. The last fiscal year had accounts receivable to sales percentage of 0.1201% compared to the same period a year earlier of 0.1114%. For the trailing twelve months investors received $0.07 in dividends for a yield of 0.18%. Last week was a very good week for investors as the stock made new highs. The stock also broke out of the trend and appears to be headed higher.


Qep Resources, Inc. has rising revenue year-over-year of $2.25 billion for 2010 vs. $1.97 billion for 2009. The bottom line has rising earnings year-over-year of $326.20 million for 2010 vs. $293.50 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $545.30 million for 2010 vs. $585.50 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Dec-100.340.25-0.09-27.41%
Sep-100.320.3200.00%
Jun-100.330.390.0619.82%

Cit Group Inc (NYSE:CIT) is a $8.01 billion market cap bank holding company, which provides commercial financing and leasing products, and management advisory services to clients in a variety of industries. CIT bank is its primary bank subsidiary. The company provides financing and leasing capital to its clients and their customers in over 30 industries and 50 countries.
The company reported (basic) $0.33 per share in earnings for the quarter ending March 31, 2011.

The current trailing twelve months (ttm) P/E ratio is 18.242 and the forward P/E ratio is 42.96. A rising P/E ratio is usually not what we want to see for an investment. The stock has a price to book ratio (ttm) of 1.06. The price to sales ratio is 3.83.

In the last month the stock has moved in price -5.49%, with a one year change of 7.39%. Comparing to the S&P500 price change, Cit Group Inc's performance is -10.87% vs. the S&P 500 from a month ago, and the one year difference is -12.68% vs. S&P 500 price change. Clearly investors have put this stock in the dog house. The stock has broken through support levels, and a 'get out of jail free card' looks unlikely in the next roll of the dice.

The annual growth rate of revenue is 284.63%.
Cit Group Inc has rising revenue year-over-year of $2.47 billion for 2010 vs. $-1,335.40 million for 2009. The bottom line has rising earnings year-over-year of $516.80 million for 2010 vs. $-3.80 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.170.330.1694.12%
Dec-100.410.37-0.04-9.11%
Sep-100.500.660.1632%
Jun-100.300.710.41136.67%
Mar-10-0.250.490.74NA%

Pharmaceutical Product Development Inc. (NASDAQ:PPDI) is a $3.48 billion market cap company. Pharmaceutical Product Development, Inc. is a global contract research organization providing drug discovery and development services.
The company reported (basic) $0.32 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 1.85. The next reporting quarter estimated mean earnings are $0.38 per share. Analyst estimates range between $0.36 and $0.4 per share.

The current trailing twelve months (ttm) P/E ratio is 25.372 and the forward P/E ratio is 16.24. The stock has a price to book ratio (ttm) of 2.54. The price to sales ratio is 2.21.

In the last month the stock has moved in price 9.26%, with a one year change of 13.22%. Comparing to the S&P500 price change, Pharmaceutical Product Development Inc's performance is 1.69% vs. the S&P 500 from a month ago, and the one year difference is 1.99% vs. S&P 500 price change.

The annual growth rate of revenue is 3.8%. The last fiscal year had accounts receivable to sales percentage of 0.3048% compared to the same period a year earlier of 0.3152%. For the trailing twelve months investors received $0.6 in dividends for a yield of 1.95%.

Pharmaceutical Product Development Inc has rising revenue year-over-year of $1.47 billion for 2010 vs. $1.42 billion for 2009. The bottom line has falling earnings year-over-year of $124.04 million for 2010 vs. $159.30 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $187.45 million for 2010 vs. $214.31 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.330.32-0.01-3.82%
Dec-100.380.40.025.68%
Sep-100.320.3200.00%
Jun-100.180.1800.00%
Mar-100.140.1400.00%

Avery Dennison Corp. (NYSE:AVY) is a $3.6 billion market cap company. Avery Dennison Corporation (Avery Dennison) develops identification and decorative solutions for businesses and consumers globally. It is engaged in the production of pressure-sensitive materials, office and consumer products and a range of tickets, tags, labels and other converted products.
The company reported (basic) $0.43 per share in earnings for the quarter ending April 2, 2011. The Quick Ratio is 0.78. The next reporting quarter estimated mean earnings are $0.75 per share. Analyst estimates range between $0.74 and $0.77 per share.

The current trailing twelve months (ttm) P/E ratio is 11.698 and the forward P/E ratio is 10.56. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 2.75. The price to sales ratio is 0.69.

In the last month the stock has moved in price -9.41%, with a one year change of -4.15%. Comparing to the S&P 500 price change, Avery Dennison Corp's performance is -14.57% vs. the S&P 500 from a month ago, and the one year difference is -22.06% vs. S&P 500 price change. While not performing all that well, Avery had a busy week last week when they warned next week was not going to be a lot of fun for investors. Expect another down day on Tuesday, unless the company also reports some type of silver lining(read 'spin').

The annual growth rate of revenue is 9.41%. The last fiscal year had accounts receivable to sales percentage of 0.1529% compared to the same period a year earlier of 0.1543%. For the trailing twelve months investors received $0.8 in dividends for a yield of 2.97%.


Avery Dennison Corp has rising revenue year-over-year of $6.51 billion for 2010 vs. $5.95 billion for 2009. The bottom line has rising earnings year-over-year of $316.90 million for 2010 vs. $-746.70 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $455.60 million for 2010 vs. $-514.30 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.470.510.048.83%
Dec-100.970.980.011.03%
Sep-100.610.620.011.36%
Jun-100.660.940.2842.49%
Mar-100.440.610.1737.11%

Hatteras Financial Corp. (NYSE:HTS) is a $2.16 billion market cap mortgage real estate investment trust (REIT). The company invests primarily in single-family residential mortgage pass-through securities guaranteed or issued by a United States Government agency (such as the Government National Mortgage Association (Ginnie Mae)), or by a United States Government-sponsored entity (such as the Federal National Mortgage Association, (Fannie Mae)), and the Federal Home Loan Mortgage Corporation, (Freddie Mac)). The company is externally managed and advised by its manager, Atlantic Capital Advisors LLC.
The company reported (basic) $0.96 per share in earnings for the quarter ending March 31, 2011. The next reporting quarter estimated mean earnings are $1.03 per share. Analyst estimates range between $0.97 and $1.09 per share.

The current trailing twelve months (ttm) P/E ratio is 7.136 and the forward P/E ratio is 7.24. A rising P/E ratio is usually not what we want to see for an investment. The stock has a price to book ratio (ttm) of 1.04. The price to sales ratio is 6.54.

In the last month the stock has moved in price 5.01%, with a one year change of -2.3%. Comparing to the S&P 500 price change, Hatteras Financial Corp's performance is -0.97% vs. the S&P 500 from a month ago, and the one year difference is -20.56% vs. S&P 500 price change.

The annual growth rate of revenue is -2.25%. For the trailing twelve months investors received $4.54 in dividends for a yield of 13.84%.


Hatteras Financial Corp has falling revenue year-over-year of $182.64 million for 2010 vs. $186.85 million for 2009. The bottom line has falling earnings year-over-year of $169.50 million for 2010 vs. $174.40 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-111.010.96-0.05-5.13%
Dec-101.010.99-0.02-1.62%
Sep-101.081.110.032.45%
Jun-101.071.01-0.06-5.99%
Mar-101.221.21-0.01-1.07%

Under Armour, Inc. (NYSE:UA) is a $4.12 billion market cap company. Under Armour, Inc. (Under Armour) is engaged in the development, marketing and distribution of branded performance apparel, footwear and accessories for men, women and youth.
The company reported (basic) $0.24 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 2.28. The next reporting quarter estimated mean earnings are $0.09 per share. Analyst estimates range between $0.05 and $0.12 per share.

The current trailing twelve months (ttm) P/E ratio is 55.713 and the forward P/E ratio is 36.71. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 5.66. The price to sales ratio is 2.64.

In the last month the stock has moved in price 7.13%, with a one year change of 115.32%. Comparing to the S&P 500 price change, Under Armour, Inc.'s performance is 1.03% vs. the S&P 500 from a month ago, and the one year difference is 75.09% vs. S&P 500 price change. The stock has had a great run, but is now at risk of not meeting the high expectations. The charts look great, but I would consider some protective put options going into earnings if I was an investor. I would also be looking to pay for them by writing some out of the money calls.

The annual growth rate of revenue is 24.23%. The last fiscal year had accounts receivable to sales percentage of 0.0959% compared to the same period a year earlier of 0.0927%.
Under Armour, Inc. has rising revenue year-over-year of $1.06 billion for 2010 vs. $856.41 million for 2009. The bottom line has rising earnings year-over-year of $68.48 million for 2010 vs. $46.79 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $112.36 million for 2010 vs. $85.27 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-110.190.230.0418.86%
Dec-100.370.440.0719.7%
Sep-100.600.680.0813.35%
Jun-100.030.070.04112.12%
Mar-100.100.140.0439.17%
Source: 9 Companies to Consider That Are Reporting Earnings on Tuesday, Part VI